Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial.
- DOI
- 10.1016/j.curtheres.2026.100839
- Published
- 2026 Dec
- Container
- Current therapeutic research, clinical and experimental
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.curtheres.2026.100839,
title = {Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial.},
author = {Spasov E and Quon D and Fukutake K and Willemze A and Dumont J and Palmborg H and Kragh N and Gerard E and Wilson A and Msihid J},
year = {2026},
journal = {Current therapeutic research, clinical and experimental},
doi = {10.1016/j.curtheres.2026.100839},
url = {https://doi.org/10.1016/j.curtheres.2026.100839}
}RIS
TY - JOUR TI - Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial. AU - Spasov E AU - Quon D AU - Fukutake K AU - Willemze A AU - Dumont J AU - Palmborg H AU - Kragh N AU - Gerard E AU - Wilson A AU - Msihid J PY - 2026 JO - Current therapeutic research, clinical and experimental DO - 10.1016/j.curtheres.2026.100839 UR - https://doi.org/10.1016/j.curtheres.2026.100839 ER -
APA
E, S., D, Q., K, F., A, W., J, D., H, P., N, K., E, G., A, W., & J, M. (2026). Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial.. Current therapeutic research, clinical and experimental. https://doi.org/10.1016/j.curtheres.2026.100839
Source records
- pubmed · retrieved 2026-09-25T21:29:30.138Z